132 related articles for article (PubMed ID: 163843)
1. Immunochemical heterogeneity of calcitonin in plasma.
Deftos LJ; Roos BA; Bronzert D; Parthemore JG
J Clin Endocrinol Metab; 1975 Mar; 40(3):409-12. PubMed ID: 163843
[TBL] [Abstract][Full Text] [Related]
2. Immunochemical heterogeneity of calcitonin in plasma of patients with medullary thryoid carcinoma.
Sizemore GW; Hpeath H; Larson JM
J Clin Invest; 1975 May; 55(5):1111-8. PubMed ID: 47335
[TBL] [Abstract][Full Text] [Related]
3. Secretion of chromogranin A by peptide-producing endocrine neoplasms.
O'Connor DT; Deftos LJ
N Engl J Med; 1986 May; 314(18):1145-51. PubMed ID: 3007986
[TBL] [Abstract][Full Text] [Related]
4. The use of region specific radioimmunoassays for characterization of circulating calcitonin in patients with medullary carcinoma of the thyroid gland.
Myhre L; Gautvik KM
Acta Endocrinol (Copenh); 1979 Jul; 91(3):449-61. PubMed ID: 474037
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the immunochemical forms of calcitonin released by a medullary thyroid carcinoma in tissue culture.
Goltzman D; Tischler AS
J Clin Invest; 1978 Feb; 61(2):449-58. PubMed ID: 621283
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of immunoreactive calcitonin in extracts of medullary thyroid carcinoma.
Rude RK; Matsumoto S; Singer FR
Miner Electrolyte Metab; 1982 Jun; 7(6):292-7. PubMed ID: 6302462
[TBL] [Abstract][Full Text] [Related]
7. Calcitonin heterogeneity in lung cancer and medullary thyroid cancer.
Becker KL; Snider RH; Silva OL; Moore CF
Acta Endocrinol (Copenh); 1978 Sep; 89(1):89-99. PubMed ID: 211777
[TBL] [Abstract][Full Text] [Related]
8. Immuno-heterogeneity of the calcitonins of hypercalcemia, breast and lung cancers and medullary carcinoma of thyroid.
Roof BS; Weinstein R; Vujic I; Burdash NM
Biomedicine; 1979 Jun; 30(2):82-90. PubMed ID: 476268
[TBL] [Abstract][Full Text] [Related]
9. [Heterogeneity of immunoreactive calcitonin in the plasma of patients with bone marrow cancer].
Moukhtar MS; Jullienne A; Taboulet J; Calmettes C; Raulais D; Milhaud G
Pathol Biol (Paris); 1975 Dec; 23(10):809-14. PubMed ID: 772524
[TBL] [Abstract][Full Text] [Related]
10. Immunochemical heterogeneity of calcitonin in man: effect on radioimmunoassay.
Snider RH; Silva OL; Moor CF; Becker KL
Clin Chim Acta; 1977 Apr; 76(1):1-14. PubMed ID: 856499
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of plasma and urinary immunoreactive calcitonin in patients with medullary carcinoma of the thyroid.
Morimoto S; Okada Y; Onishi T; Takai S; Miyauchi A; Lee S; Nishioka Y; Kumahara Y
Endocrinol Jpn; 1981 Oct; 28(5):583-94. PubMed ID: 7344949
[TBL] [Abstract][Full Text] [Related]
12. Heterogeneity of immunoreactive calcitonin in extracts of normal human thyroid.
Woloszczuk W; Kovarik J
Horm Metab Res; 1981 Aug; 13(8):460-3. PubMed ID: 6173296
[TBL] [Abstract][Full Text] [Related]
13. Calcitonin immunoreactivity and hypercalcitoninemia in two patients with sporadic, nonfamilial, gastroenteropancreatic neuroendocrine tumors.
McLeod MK; Vinik AI
Surgery; 1992 May; 111(5):484-8. PubMed ID: 1350867
[TBL] [Abstract][Full Text] [Related]
14. Immunochemical heterogeneity of calcitonin in tumor, tumor venous effluent, and peripheral blood of patients with medullary thyroid carcinoma.
Heath H; Sizemore GW
J Lab Clin Med; 1979 Mar; 93(3):390-401. PubMed ID: 429850
[No Abstract] [Full Text] [Related]
15. Letter: Hypersecretion of calcitonin in neoplastic conditions.
Milhaud G; Calmette C; Taboulet J; Julienne A; Moukhtar MS
Lancet; 1974 Mar; 1(7855):462-3. PubMed ID: 4131473
[No Abstract] [Full Text] [Related]
16. Production of immunoreactive corticotropin-releasing hormone in various neuroendocrine tumors.
Tsuchihashi T; Yamaguchi K; Abe K; Yanaihara N; Saito S
Jpn J Clin Oncol; 1992 Aug; 22(4):232-7. PubMed ID: 1359172
[TBL] [Abstract][Full Text] [Related]
17. Application of non-commercial methods for estimation of immunoreactive serum calcitonin in clinical practice (comparison of two methods).
Bednár J; Neradilová M; Soutorová M; Bílek R; Nĕmec J; Pechová M; Havelka J
Czech Med; 1991; 14(4):205-12. PubMed ID: 1842705
[TBL] [Abstract][Full Text] [Related]
18. Hypercalcitoninaemia in medullary carcinoma of the thyroid and other malignancies: value of calcitonin as tumour marker.
Marrinan M; Skrabanek P; Moriarty M; McPartlin J; Powell D
Horm Metab Res; 1982 Apr; 14(4):213-5. PubMed ID: 6282727
[TBL] [Abstract][Full Text] [Related]
19. Multiple immunoreactive forms of calcitonin in human plasma.
Singer FR; Habener JF
Biochem Biophys Res Commun; 1974 Nov; 61(2):710-6. PubMed ID: 4477010
[No Abstract] [Full Text] [Related]
20. Calcitonin heterogeneity: in vivo and in vitro studies.
Roos BA; Parthemore JG; Lee JC; Deftos LJ
Calcif Tissue Res; 1977 May; 22 Suppl():298-302. PubMed ID: 199331
[No Abstract] [Full Text] [Related]
[Next] [New Search]
